Cardiac MR, PET, CT Program, Department of Radiology, Division of Cardiology, Massachusetts General Hospital, Boston, USA.
Am Heart J. 2011 Aug;162(2):283-290.e2. doi: 10.1016/j.ahj.2011.04.017.
To determine the adherence to national guidelines and in-hospital mortality of older patients with acute myocardial infarction (AMI) using a national database.
Prior studies have demonstrated that older patients are less likely to receive evidence-based therapies.
Using data from the GWTG-CAD, we examined care and in-hospital outcomes among AMI patients treated at 416 US centers from 2000 to 2009. Evidence-based medical therapy, other quality measures, and in-hospital post-AMI mortality were analyzed.
A total of 156,677 patients were included in the study; 21.7% (n = 33,997) were aged ≥80 years, 33.0% (n = 51,773) 65 to 79 years, and 45.3% (n = 70,907) 18 to 64 years. Older patients had higher prevalence of comorbidities compared to younger patients. Overall, compliance with evidence-based medical treatment upon admission and discharge was high, but age-related differences in care were seen for most measures. After multivariate adjustment, the mortality of the patients aged ≥80 years was substantially higher compared to the youngest cohort (adjusted OR 3.4, 95% CI 3.2-3.8, P < .0001). There were substantial improvements in AMI quality measures over time in each age group.
Among AMI patients aged ≥80 years, the use of evidence-based therapies was high and significant improvements over time have been observed in a national quality improvement program. Nevertheless, there remain important age-related gaps in care and outcomes, suggesting opportunities exist to improve prognosis in this high-risk population.
利用国家数据库确定老年急性心肌梗死(AMI)患者对国家指南的依从性和院内死亡率。
先前的研究表明,老年患者接受循证治疗的可能性较低。
使用来自 GWTG-CAD 的数据,我们检查了 2000 年至 2009 年在 416 个美国中心治疗的 AMI 患者的护理和院内结果。分析了循证药物治疗、其他质量指标和 AMI 后院内死亡率。
共有 156677 名患者纳入研究;年龄≥80 岁的患者占 21.7%(n=33997),65-79 岁的患者占 33.0%(n=51773),18-64 岁的患者占 45.3%(n=70907)。与年轻患者相比,老年患者的合并症患病率更高。总体而言,入院和出院时接受循证药物治疗的依从性较高,但大多数指标的护理存在与年龄相关的差异。多变量调整后,与最年轻队列相比,≥80 岁患者的死亡率明显更高(调整后的 OR 3.4,95%CI 3.2-3.8,P<.0001)。在每个年龄组中,AMI 质量指标随着时间的推移都有了实质性的提高。
在≥80 岁的 AMI 患者中,循证治疗的应用率较高,并且在国家质量改进计划中观察到随着时间的推移有了显著的改善。然而,在护理和结果方面仍存在重要的与年龄相关的差距,这表明在这个高风险人群中存在改善预后的机会。